Rather than simply suppressing appetite, it recalibrates the brains response to food stimuli, lowering cravings and reducing the reward-driven urge to overeat
Topics worth discussing include current BMI and whether FDA criteria are met, existing health conditions that might affect medication selection, current medications and potential interactions, realistic outcome expectations, expected treatment duration, and what happens if treatment is discontinued
The drug amplifies all of these effects, which is why it lowers blood sugar and reduces how much you eat
The SURPASS-2 trial treated patients with type 2 diabetes with Tirzepatide and Semaglutide (Ozempic)
DSIP also demonstrates neuroprotective effects, including antioxidant properties and stroke recovery benefits